[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Drugs of Abuse Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

August 2022 | 85 pages | ID: GE377627A007EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Drugs of Abuse Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drugs of Abuse Testing market size is estimated to be worth US$ 2957.6 million in 2021 and is forecast to a readjusted size of USD 4003 million by 2028 with a CAGR of 4.4% during review period. Hospitals accounting for % of the Drugs of Abuse Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Psychostimulants segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Drugs of Abuse Testing include Quest Diagnostics, F. Hoffmann La-Roche, Siemens, Thermo Fisher Scientific, and Abbott, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Drugs of Abuse Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
  • Psychostimulants
  • Narcotic
  • Hallucinogens
  • Sedatives
  • Others
Market segment by Application, can be divided into
  • Hospitals
  • Diagnostics Laboratories
  • Forensic Laboratories
  • Others
Market segment by players, this report covers
  • Quest Diagnostics
  • F. Hoffmann La-Roche
  • Siemens
  • Thermo Fisher Scientific
  • Abbott
  • Shimadzu
  • Laboratory Corporation of America
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Drugs of Abuse Testing product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Drugs of Abuse Testing, with revenue, gross margin and global market share of Drugs of Abuse Testing from 2019 to 2022.

Chapter 3, the Drugs of Abuse Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Drugs of Abuse Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Drugs of Abuse Testing research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Drugs of Abuse Testing
1.2 Classification of Drugs of Abuse Testing by Type
  1.2.1 Overview: Global Drugs of Abuse Testing Market Size by Type: 2017 Versus 2021 Versus 2028
  1.2.2 Global Drugs of Abuse Testing Revenue Market Share by Type in 2021
  1.2.3 Psychostimulants
  1.2.4 Narcotic
  1.2.5 Hallucinogens
  1.2.6 Sedatives
  1.2.7 Others
1.3 Global Drugs of Abuse Testing Market by Application
  1.3.1 Overview: Global Drugs of Abuse Testing Market Size by Application: 2017 Versus 2021 Versus 2028
  1.3.2 Hospitals
  1.3.3 Diagnostics Laboratories
  1.3.4 Forensic Laboratories
  1.3.5 Others
1.4 Global Drugs of Abuse Testing Market Size & Forecast
1.5 Global Drugs of Abuse Testing Market Size and Forecast by Region
  1.5.1 Global Drugs of Abuse Testing Market Size by Region: 2017 VS 2021 VS 2028
  1.5.2 Global Drugs of Abuse Testing Market Size by Region, (2017-2022)
  1.5.3 North America Drugs of Abuse Testing Market Size and Prospect (2017-2028)
  1.5.4 Europe Drugs of Abuse Testing Market Size and Prospect (2017-2028)
  1.5.5 Asia-Pacific Drugs of Abuse Testing Market Size and Prospect (2017-2028)
  1.5.6 South America Drugs of Abuse Testing Market Size and Prospect (2017-2028)
  1.5.7 Middle East and Africa Drugs of Abuse Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
  1.6.1 Drugs of Abuse Testing Market Drivers
  1.6.2 Drugs of Abuse Testing Market Restraints
  1.6.3 Drugs of Abuse Testing Trends Analysis

2 COMPANY PROFILES

2.1 Quest Diagnostics
  2.1.1 Quest Diagnostics Details
  2.1.2 Quest Diagnostics Major Business
  2.1.3 Quest Diagnostics Drugs of Abuse Testing Product and Solutions
  2.1.4 Quest Diagnostics Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.1.5 Quest Diagnostics Recent Developments and Future Plans
2.2 F. Hoffmann La-Roche
  2.2.1 F. Hoffmann La-Roche Details
  2.2.2 F. Hoffmann La-Roche Major Business
  2.2.3 F. Hoffmann La-Roche Drugs of Abuse Testing Product and Solutions
  2.2.4 F. Hoffmann La-Roche Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.2.5 F. Hoffmann La-Roche Recent Developments and Future Plans
2.3 Siemens
  2.3.1 Siemens Details
  2.3.2 Siemens Major Business
  2.3.3 Siemens Drugs of Abuse Testing Product and Solutions
  2.3.4 Siemens Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.3.5 Siemens Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
  2.4.1 Thermo Fisher Scientific Details
  2.4.2 Thermo Fisher Scientific Major Business
  2.4.3 Thermo Fisher Scientific Drugs of Abuse Testing Product and Solutions
  2.4.4 Thermo Fisher Scientific Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Abbott
  2.5.1 Abbott Details
  2.5.2 Abbott Major Business
  2.5.3 Abbott Drugs of Abuse Testing Product and Solutions
  2.5.4 Abbott Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.5.5 Abbott Recent Developments and Future Plans
2.6 Shimadzu
  2.6.1 Shimadzu Details
  2.6.2 Shimadzu Major Business
  2.6.3 Shimadzu Drugs of Abuse Testing Product and Solutions
  2.6.4 Shimadzu Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.6.5 Shimadzu Recent Developments and Future Plans
2.7 Laboratory Corporation of America
  2.7.1 Laboratory Corporation of America Details
  2.7.2 Laboratory Corporation of America Major Business
  2.7.3 Laboratory Corporation of America Drugs of Abuse Testing Product and Solutions
  2.7.4 Laboratory Corporation of America Drugs of Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.7.5 Laboratory Corporation of America Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Drugs of Abuse Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
  3.2.1 Top 3 Drugs of Abuse Testing Players Market Share in 2021
  3.2.2 Top 10 Drugs of Abuse Testing Players Market Share in 2021
  3.2.3 Market Competition Trend
3.3 Drugs of Abuse Testing Players Head Office, Products and Services Provided
3.4 Drugs of Abuse Testing Mergers & Acquisitions
3.5 Drugs of Abuse Testing New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Drugs of Abuse Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Drugs of Abuse Testing Market Forecast by Type (2023-2028)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Drugs of Abuse Testing Revenue Market Share by Application (2017-2022)
5.2 Global Drugs of Abuse Testing Market Forecast by Application (2023-2028)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America Drugs of Abuse Testing Revenue by Type (2017-2028)
6.2 North America Drugs of Abuse Testing Revenue by Application (2017-2028)
6.3 North America Drugs of Abuse Testing Market Size by Country
  6.3.1 North America Drugs of Abuse Testing Revenue by Country (2017-2028)
  6.3.2 United States Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  6.3.3 Canada Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  6.3.4 Mexico Drugs of Abuse Testing Market Size and Forecast (2017-2028)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe Drugs of Abuse Testing Revenue by Type (2017-2028)
7.2 Europe Drugs of Abuse Testing Revenue by Application (2017-2028)
7.3 Europe Drugs of Abuse Testing Market Size by Country
  7.3.1 Europe Drugs of Abuse Testing Revenue by Country (2017-2028)
  7.3.2 Germany Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  7.3.3 France Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  7.3.4 United Kingdom Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  7.3.5 Russia Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  7.3.6 Italy Drugs of Abuse Testing Market Size and Forecast (2017-2028)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific Drugs of Abuse Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Drugs of Abuse Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Drugs of Abuse Testing Market Size by Region
  8.3.1 Asia-Pacific Drugs of Abuse Testing Revenue by Region (2017-2028)
  8.3.2 China Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  8.3.3 Japan Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  8.3.4 South Korea Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  8.3.5 India Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  8.3.6 Southeast Asia Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  8.3.7 Australia Drugs of Abuse Testing Market Size and Forecast (2017-2028)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America Drugs of Abuse Testing Revenue by Type (2017-2028)
9.2 South America Drugs of Abuse Testing Revenue by Application (2017-2028)
9.3 South America Drugs of Abuse Testing Market Size by Country
  9.3.1 South America Drugs of Abuse Testing Revenue by Country (2017-2028)
  9.3.2 Brazil Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  9.3.3 Argentina Drugs of Abuse Testing Market Size and Forecast (2017-2028)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa Drugs of Abuse Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Drugs of Abuse Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Drugs of Abuse Testing Market Size by Country
  10.3.1 Middle East & Africa Drugs of Abuse Testing Revenue by Country (2017-2028)
  10.3.2 Turkey Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  10.3.3 Saudi Arabia Drugs of Abuse Testing Market Size and Forecast (2017-2028)
  10.3.4 UAE Drugs of Abuse Testing Market Size and Forecast (2017-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

LIST OF TABLES

Table 1. Global Drugs of Abuse Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Drugs of Abuse Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Drugs of Abuse Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Drugs of Abuse Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Drugs of Abuse Testing Revenue Market Share by Region (2023-2028)
Table 6. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 7. Quest Diagnostics Major Business
Table 8. Quest Diagnostics Drugs of Abuse Testing Product and Solutions
Table 9. Quest Diagnostics Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. F. Hoffmann La-Roche Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann La-Roche Major Business
Table 12. F. Hoffmann La-Roche Drugs of Abuse Testing Product and Solutions
Table 13. F. Hoffmann La-Roche Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Siemens Corporate Information, Head Office, and Major Competitors
Table 15. Siemens Major Business
Table 16. Siemens Drugs of Abuse Testing Product and Solutions
Table 17. Siemens Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Drugs of Abuse Testing Product and Solutions
Table 21. Thermo Fisher Scientific Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Abbott Corporate Information, Head Office, and Major Competitors
Table 23. Abbott Major Business
Table 24. Abbott Drugs of Abuse Testing Product and Solutions
Table 25. Abbott Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Shimadzu Corporate Information, Head Office, and Major Competitors
Table 27. Shimadzu Major Business
Table 28. Shimadzu Drugs of Abuse Testing Product and Solutions
Table 29. Shimadzu Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Laboratory Corporation of America Corporate Information, Head Office, and Major Competitors
Table 31. Laboratory Corporation of America Major Business
Table 32. Laboratory Corporation of America Drugs of Abuse Testing Product and Solutions
Table 33. Laboratory Corporation of America Drugs of Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Global Drugs of Abuse Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 35. Global Drugs of Abuse Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 36. Breakdown of Drugs of Abuse Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Drugs of Abuse Testing Players Head Office, Products and Services Provided
Table 38. Drugs of Abuse Testing Mergers & Acquisitions in the Past Five Years
Table 39. Drugs of Abuse Testing New Entrants and Expansion Plans
Table 40. Global Drugs of Abuse Testing Revenue (USD Million) by Type (2017-2022)
Table 41. Global Drugs of Abuse Testing Revenue Share by Type (2017-2022)
Table 42. Global Drugs of Abuse Testing Revenue Forecast by Type (2023-2028)
Table 43. Global Drugs of Abuse Testing Revenue by Application (2017-2022)
Table 44. Global Drugs of Abuse Testing Revenue Forecast by Application (2023-2028)
Table 45. North America Drugs of Abuse Testing Revenue by Type (2017-2022) & (USD Million)
Table 46. North America Drugs of Abuse Testing Revenue by Type (2023-2028) & (USD Million)
Table 47. North America Drugs of Abuse Testing Revenue by Application (2017-2022) & (USD Million)
Table 48. North America Drugs of Abuse Testing Revenue by Application (2023-2028) & (USD Million)
Table 49. North America Drugs of Abuse Testing Revenue by Country (2017-2022) & (USD Million)
Table 50. North America Drugs of Abuse Testing Revenue by Country (2023-2028) & (USD Million)
Table 51. Europe Drugs of Abuse Testing Revenue by Type (2017-2022) & (USD Million)
Table 52. Europe Drugs of Abuse Testing Revenue by Type (2023-2028) & (USD Million)
Table 53. Europe Drugs of Abuse Testing Revenue by Application (2017-2022) & (USD Million)
Table 54. Europe Drugs of Abuse Testing Revenue by Application (2023-2028) & (USD Million)
Table 55. Europe Drugs of Abuse Testing Revenue by Country (2017-2022) & (USD Million)
Table 56. Europe Drugs of Abuse Testing Revenue by Country (2023-2028) & (USD Million)
Table 57. Asia-Pacific Drugs of Abuse Testing Revenue by Type (2017-2022) & (USD Million)
Table 58. Asia-Pacific Drugs of Abuse Testing Revenue by Type (2023-2028) & (USD Million)
Table 59. Asia-Pacific Drugs of Abuse Testing Revenue by Application (2017-2022) & (USD Million)
Table 60. Asia-Pacific Drugs of Abuse Testing Revenue by Application (2023-2028) & (USD Million)
Table 61. Asia-Pacific Drugs of Abuse Testing Revenue by Region (2017-2022) & (USD Million)
Table 62. Asia-Pacific Drugs of Abuse Testing Revenue by Region (2023-2028) & (USD Million)
Table 63. South America Drugs of Abuse Testing Revenue by Type (2017-2022) & (USD Million)
Table 64. South America Drugs of Abuse Testing Revenue by Type (2023-2028) & (USD Million)
Table 65. South America Drugs of Abuse Testing Revenue by Application (2017-2022) & (USD Million)
Table 66. South America Drugs of Abuse Testing Revenue by Application (2023-2028) & (USD Million)
Table 67. South America Drugs of Abuse Testing Revenue by Country (2017-2022) & (USD Million)
Table 68. South America Drugs of Abuse Testing Revenue by Country (2023-2028) & (USD Million)
Table 69. Middle East & Africa Drugs of Abuse Testing Revenue by Type (2017-2022) & (USD Million)
Table 70. Middle East & Africa Drugs of Abuse Testing Revenue by Type (2023-2028) & (USD Million)
Table 71. Middle East & Africa Drugs of Abuse Testing Revenue by Application (2017-2022) & (USD Million)
Table 72. Middle East & Africa Drugs of Abuse Testing Revenue by Application (2023-2028) & (USD Million)
Table 73. Middle East & Africa Drugs of Abuse Testing Revenue by Country (2017-2022) & (USD Million)
Table 74. Middle East & Africa Drugs of Abuse Testing Revenue by Country (2023-2028) & (USD Million)

LIST OF FIGURES

Figure 1. Drugs of Abuse Testing Picture
Figure 2. Global Drugs of Abuse Testing Revenue Market Share by Type in 2021
Figure 3. Psychostimulants
Figure 4. Narcotic
Figure 5. Hallucinogens
Figure 6. Sedatives
Figure 7. Others
Figure 8. Drugs of Abuse Testing Revenue Market Share by Application in 2021
Figure 9. Hospitals Picture
Figure 10. Diagnostics Laboratories Picture
Figure 11. Forensic Laboratories Picture
Figure 12. Others Picture
Figure 13. Global Drugs of Abuse Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Drugs of Abuse Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Drugs of Abuse Testing Revenue Market Share by Region (2017-2028)
Figure 16. Global Drugs of Abuse Testing Revenue Market Share by Region in 2021
Figure 17. North America Drugs of Abuse Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Drugs of Abuse Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Drugs of Abuse Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Drugs of Abuse Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Drugs of Abuse Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Drugs of Abuse Testing Market Drivers
Figure 23. Drugs of Abuse Testing Market Restraints
Figure 24. Drugs of Abuse Testing Market Trends
Figure 25. Quest Diagnostics Recent Developments and Future Plans
Figure 26. F. Hoffmann La-Roche Recent Developments and Future Plans
Figure 27. Siemens Recent Developments and Future Plans
Figure 28. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 29. Abbott Recent Developments and Future Plans
Figure 30. Shimadzu Recent Developments and Future Plans
Figure 31. Laboratory Corporation of America Recent Developments and Future Plans
Figure 32. Global Drugs of Abuse Testing Revenue Share by Players in 2021
Figure 33. Drugs of Abuse Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Drugs of Abuse Testing Revenue Market Share in 2021
Figure 35. Global Top 10 Players Drugs of Abuse Testing Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Drugs of Abuse Testing Revenue Share by Type in 2021
Figure 38. Global Drugs of Abuse Testing Market Share Forecast by Type (2023-2028)
Figure 39. Global Drugs of Abuse Testing Revenue Share by Application in 2021
Figure 40. Global Drugs of Abuse Testing Market Share Forecast by Application (2023-2028)
Figure 41. North America Drugs of Abuse Testing Sales Market Share by Type (2017-2028)
Figure 42. North America Drugs of Abuse Testing Sales Market Share by Application (2017-2028)
Figure 43. North America Drugs of Abuse Testing Revenue Market Share by Country (2017-2028)
Figure 44. United States Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Drugs of Abuse Testing Sales Market Share by Type (2017-2028)
Figure 48. Europe Drugs of Abuse Testing Sales Market Share by Application (2017-2028)
Figure 49. Europe Drugs of Abuse Testing Revenue Market Share by Country (2017-2028)
Figure 50. Germany Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Drugs of Abuse Testing Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Drugs of Abuse Testing Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Drugs of Abuse Testing Revenue Market Share by Region (2017-2028)
Figure 58. China Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Drugs of Abuse Testing Sales Market Share by Type (2017-2028)
Figure 65. South America Drugs of Abuse Testing Sales Market Share by Application (2017-2028)
Figure 66. South America Drugs of Abuse Testing Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Drugs of Abuse Testing Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Drugs of Abuse Testing Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Drugs of Abuse Testing Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Drugs of Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source


More Publications